KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Total Debt (2020 - 2021)

Ginkgo Bioworks Holdings filings provide 2 years of Total Debt readings, the most recent being $631638.0 for Q2 2021.

  • On a quarterly basis, Total Debt changed N/A to $631638.0 in Q2 2021 year-over-year; TTM through Jun 2021 was $631638.0, a N/A change, with the full-year FY2020 number at $156333.0, changed N/A from a year prior.
  • Total Debt hit $631638.0 in Q2 2021 for Ginkgo Bioworks Holdings, up from $156333.0 in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $631638.0 in Q2 2021 to a low of $156333.0 in Q4 2020.